SCHEMBL30865402

SCHEMBL30865402

O=C(N1CC2(CC(n3cnc(C(F)(F)F)n3)C2)C1)N1CC2(CN(Cc3cnn(C(F)F)c3)C2)C1

nearest known ligand 0.42

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 6/20 0.42
▸ USP2 O75604 1/20 0.30
▸ CYP2D6 P10635 1/20 0.30
▸ GRM2 Q14416 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30865435 0.88 MGLL (0.43) MGLLUSP2CYP2D6
SCHEMBL30865483 0.86 MGLL (0.45) MGLLUSP2CYP2D6
SCHEMBL30865156 0.86 MGLL (0.53) MGLLCYP2D6GRM2
SCHEMBL30865405 0.80 MGLL (0.46) MGLL
SCHEMBL30865431 0.80 MGLL (0.46) MGLL
SCHEMBL30865299 0.79 MGLL (0.41) MGLL
SCHEMBL30865441 0.79 MGLL (0.45) MGLL
SCHEMBL30865373 0.79 MGLL (0.42) MGLL
SCHEMBL30865167 0.78 MGLL (0.44) MGLL
SCHEMBL27246295 0.78 MGLL (0.40) MGLLUSP2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4608823-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF MONOACYLGLYCEROL LIPASE (MAGL) F. Hoffmann-La Roche AG (CH) 2025-09-03 — — EP claimed
WO-2024088922-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF MONOACYLGLYCEROL LIPASE (MAGL) F. HOFFMANN-LA ROCHE AG (CH) 2024-05-02 — — WO claimed
EP-4608823-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF MONOACYLGLYCEROL LIPASE (MAGL) F. Hoffmann-La Roche AG (CH) 2025-09-03 — — EP disclosed
WO-2024088922-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF MONOACYLGLYCEROL LIPASE (MAGL) F. HOFFMANN-LA ROCHE AG (CH) 2024-05-02 — — WO disclosed
Send feedback